(Des-Thr7)-Glucagon, CAS: 1802078-28-9
Sequence: H-HSQGTFSDYSKYLDSRRAQDFVQWLMNT-OH
Showing 1–16 of 638 results
-
-
A21G-Beta-Amyloid (1-42) HFIP treated
Sequence: DAEFRHDSGYEVHHQKLVFFGEDVGSNKGAIIGLMVGGVVIA Specifications: Point mutated synthetic Beta-Amyloid peptide (1-42)
-
A2T-Beta-Amyloid (1-40) HFIP treated
Sequence: DTEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV Specifications: Point mutated synthetic A beta peptide (1-40)
-
A2T-Beta-Amyloid (1-42) HFIP treated
Sequence: DTEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA Specifications: Point mutated synthetic Beta-Amyloid peptide (1-42)
-
A2V-Beta-Amyloid (1-40) HFIP treated
Sequence: DVEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV Specifications: Point mutated synthetic A beta peptide (1-40)
-
A2V-Beta-Amyloid (1-42) HFIP treated
Sequence: DVEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA Specifications: Point mutated synthetic Beta-Amyloid peptide (1-42)
-
Acetylome – Acetyltransferase Microarray
Sequence: See Sequence List under Product Documentation Specifications: 13 mer peptides selected form the human proteome
-
Acetylome – Deacetylase Microarray
Sequence: See Sequence List under Product Documentation Specifications: 13 mer peptides selected form the human proteome
-
-
-
Antigen Peptide BCL 2 HLA-A*0201 (WLSLKTLLSL)
Sequence: H-WLSLKTLLSL-OH Specifications: 10mer peptide as TFA salt
-
Antigen Peptide BKV VP1 HLA-A*0201 (AITEVECFL)
Sequence: H-AITEVECFL-OH Specifications: 9mer peptide as TFA salt
-
Antigen Peptide BST-2 HLA-A*0201 (KLQDASAEV)
Sequence: H-KLQDASAEV-OH Specifications: 9mer peptide as TFA salt
-
Antigen Peptide Capsid protein H2-Ld (VPQYGYLTL)
Sequence: H-VPQYGYLTL-OH Specifications: 9mer peptide as TFA salt
-
Antigen Peptide CD antigen HLA-A*0201 (SLFLGILSV)
Sequence: H-SLFLGILSV-OH Specifications: 9mer peptide as TFA salt
-
Antigen Peptide CD antigen HLA-A*0203 (TLKDGIIMI)
Sequence: H-TLKDGIIMI-OH Specifications: 9mer peptide as TFA salt
